Uganda · Pathology-led capacity
We build distributed pathology capacity around the people and equipment laboratories already have.
Cytology and histology. Physical care and digital coordination. Qualified pathologists retain diagnostic responsibility.
A service built around reality
Good preparation. Skilled people. A path to specialist review. Each part has to work.
Kebeza’s clinical work came before its software. Several years of regional cytology work now inform a broader model: strengthen local diagnostic capacity, organise scarce expertise and develop acquisition tools that reduce the need for specialists to be physically beside every microscope.
How PathEdge fitsMulago National Referral Hospital, Uganda
Rosemary operates within pathology services at Mulago National Referral Hospital, helping patients check whether their results are ready, request FNAC appointments and navigate the next step in their care.
Rosemary supports access; it does not diagnose cancer. Multilingual integration with Sunbird is in development.
About Mulago Official hospital information
One connected direction
Explore the parts of Kebeza and the work that connects them. Current services, platform development and future research have different starting points.
The Kebeza Project explains cancer concerns in Luganda and English. Cancer Check helps people organise symptoms and find a next step. Outreach and screening camps connect awareness to assessment.
Collection, preparation and staining make remote review possible. Regional experience with affiliated clinics spans Mbale Pathology Clinic, JPC Pathology Clinic in Jinja and Oak Pathology Clinic in Arua, alongside trained operators and cytotechnologists.
PathEdge is being developed to coordinate acquisition, remote review, second opinions and quality assurance across cytology and histology. Pathologists interpret and sign final reports.
Rosemary operates within pathology services at Mulago National Referral Hospital, Uganda. It helps patients check result readiness, request FNAC appointments and navigate services. Further referral and follow-up coordination is planned.
Image and glass-slide rereads, discrepancy review and prospective evaluation would test the workflows. APIR, the head-and-neck registry and cervical screening studies form the proposed evidence programme.
The proposed African Precision Oncology Atlas would bring pathology, clinical and molecular findings together with reviewed evidence for human-supervised oncology and tumour-board workflows.
PathEdge · Platform in development
A scanner-agnostic approach to remote pathology, with trained local teams and accountable specialist review.
Sparse abnormal cells, background clues and focal depth all affect what a reviewer can see. Screening and systematic capture need the right expertise.
Reliable focus, colour and full tissue context support interpretation. Extra levels and ancillary studies remain part of clinical practice.
Targets to validate
These are pathway targets for suitable cases, subject to evaluation. They are not service guarantees or measured network-wide performance.
From sampling to report when same-day preparation and review are feasible.
From tissue receipt at the laboratory, for suitable routine cases.
For digital acquisition and remote sign-out once a suitable conventional slide already exists.
Extra levels, ancillary studies, immunohistochemistry, difficult consultations and inadequate samples require their own timelines.
Built through practice
MBChB, MMed (Path)
Founder, Kebeza Consultancy Ltd. Associate Consultant Pathologist at Mulago National Referral Hospital, where he leads pathology resident training.
Clinical practice and regional service experience shape the company’s choices: protect specimen quality, support the workforce and evaluate each new tool against the work it must do.
Kebeza is a separate venture. Institutional roles do not imply a commercial endorsement.
Start a conversationBuild the next layer with us
